These Analysts Revise Their Forecasts On Caris Life Sciences Following Q4 Earnings

Caris Life Sciences Inc. (NASDAQ:CAI) on Thursday posted better-than-expected fourth-quarter earnings.Caris Life Sciences on Thursday reported fourth-quarter earnings of 28 cents compared to the consensus loss of 3 cents. Sales for the quarter jumped 125% year over year to $292.89 million, beating the consensus of $208.63 million."Demand for our platform continued to accelerate in 2025, driving strong growth in volume and revenue and expanding adoption across our solutions. We are focused on building on thi ...